Post by Tresquare Technologies

At EuroPCR in Paris, from May 18–21, Tresquare Technologies will be joining the global interventional cardiology community to advance the future of structural heart therapies. Our mission is clear: improving treatment options for patients with aortic stenosis. We are proud to showcase TRESECT® — the only device designed to enable complete resection and removal of degenerated bioprosthetic valve leaflets, facilitating Valve-in-Valve procedures and supporting improved procedural and hemodynamic outcomes. We look forward to connecting with physicians, partners, and innovators who share our commitment to improving patient care in structural heart disease. #EuroPCR #StructuralHeart #AorticStenosis #ValveInValve #MedTech #InterventionalCardiology #Innovation #Tresquare